We found that FBL expressions in CD19+ B cells and CD4+ T cells of SLE patients were lower than that of healthy controls (Supplementary Figures 3B, C), suggesting that FBL may play an immunomodulatory role. Here, CD4 is linked to systemic lupus erythematosus.